Acute Myeloid Leukemia in Adults

We offer compassionate care throughout the diagnosis and treatment of acute myeloid leukemia, a rapidly growing cancer of blood-forming cells in the bone marrow, the spongy tissue in the center of bones. Our hematologist–oncologists use the latest diagnostic tools, such as molecular profiling and chromosome analysis, to create a personalized treatment plan for you. Our goal is to manage this cancer quickly with the goal of achieving remission, in which cancer cells are no longer detected in the blood.

Clinical Trials and Research Studies

Phase 1

A Phase 1 Study Evaluating Safety Tolerability and Pharmacokinetics of Escalating Doses of AGS62P1 Given as Monotherapy in Subjects with Acute Myeloid Leukemia (AML)

Phase 2

AALL1521: INCB 18424-269 A Phase 2 Study of the JAK1/JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High-Risk CRLF2-Rearranged and/or JAK Pathway-Mutant Acute Lymphoblastic Leukemia (ALL)

Phase 3

AALL1331; Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND# 117467 NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)

Phase 3

Treatment Of Patients Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) Or Localized B-Lineage Lymphoblastic Lymphoma